BDBM375942 US10947243, Example 8::US9914735, Example 8

SMILES COc1cc(ccc1O)-c1cc2nn(C)cc2c(O[C@H](C)[C@H]2CNC(=O)C2)n1

InChI Key InChIKey=HLVQIKPORSSRAI-UHFFFAOYSA-N

Data  30 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 30 hits for monomerid = 375942   

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 27.4nMAssay Description:Recombinant human Syk (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag, affinity-purified and deep-frozen at a conc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
Go to US Patent

TargetGlycogen synthase kinase-3 beta(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 1.00E+4nMAssay Description:FLT3 is obtained from Invitrogen in 50 mM Tris (pH7.5); 100 mM NaCl; 0.05 mM EDTA, 0.05% NP-40, 2 mM DTT; 50% Glycerol # PV3182; Lot 286671; sequence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 369nMAssay Description:Recombinant human Aurora B (amino acids 1-344, clone number DU1773, Molecular weight 40.2 kDa, University of Dundee) was expressed as a fusion protei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
Go to US Patent

TargetAurora kinase B(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 643nMAssay Description:Recombinant human Syk (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag, affinity-purified and deep-frozen at a conc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 1nMAssay Description:Human GSK3beta (expressed and prified from SF21 cells) is obtained from the University Dundee/Scotland (Dr. James Hastie Dept. of Biochemistry) in 50...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
Go to US Patent

TargetGlycogen synthase kinase-3 beta(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 1.00E+4nMAssay Description:FLT3 is obtained from Invitrogen in 50 mM Tris (pH7.5); 100 mM NaCl; 0.05 mM EDTA, 0.05% NP-40, 2 mM DTT; 50% Glycerol # PV3182; Lot 286671; sequence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 369nMAssay Description:Recombinant human Aurora B (amino acids 1-344, clone number DU1773, Molecular weight 40.2 kDa, University of Dundee) was expressed as a fusion protei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
Go to US Patent

TargetAurora kinase B(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 643nMAssay Description:Recombinant human Syk (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag, affinity-purified and deep-frozen at a conc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 1nMAssay Description:Human GSK3beta (expressed and prified from SF21 cells) is obtained from the University Dundee/Scotland (Dr. James Hastie Dept. of Biochemistry) in 50...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
Go to US Patent

TargetGlycogen synthase kinase-3 beta(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 1.00E+4nMAssay Description:FLT3 is obtained from Invitrogen in 50 mM Tris (pH7.5); 100 mM NaCl; 0.05 mM EDTA, 0.05% NP-40, 2 mM DTT; 50% Glycerol # PV3182; Lot 286671; sequence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 1.35E+4nMAssay Description:Recombinant human Aurora B (amino acids 1-344, clone number DU1773, Molecular weight 40.2 kDa, University of Dundee) was expressed as a fusion protei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
Go to US Patent

TargetAurora kinase B(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 5.00E+4nMAssay Description:Recombinant human Syk (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag, affinity-purified and deep-frozen at a conc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK [342-635](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 27.4nMAssay Description:Human GSK3beta (expressed and prified from SF21 cells) is obtained from the University Dundee/Scotland (Dr. James Hastie Dept. of Biochemistry) in 50...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 1.35E+4nMAssay Description:FLT3 is obtained from Invitrogen in 50 mM Tris (pH7.5); 100 mM NaCl; 0.05 mM EDTA, 0.05% NP-40, 2 mM DTT; 50% Glycerol # PV3182; Lot 286671; sequence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
Go to US Patent

TargetAurora kinase B(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 5.00E+4nMAssay Description:Recombinant human Aurora B (amino acids 1-344, clone number DU1773, Molecular weight 40.2 kDa, University of Dundee) was expressed as a fusion protei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 27.4nMAssay Description:Recombinant human Syk (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag, affinity-purified and deep-frozen at a conc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2020
Entry Details
Go to US Patent

TargetGlycogen synthase kinase-3 beta(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 1.00E+4nMAssay Description:Human GSK3beta (expressed and prified from SF21 cells) is obtained from the University Dundee/Scotland (Dr. James Hastie—Dept. of Biochemistry) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2020
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 369nMAssay Description:FLT3 is obtained from Invitrogen in 50 mM Tris (pH7.5); 100 mM NaCl; 0.05 mM EDTA, 0.05% NP-40, 2 mM DTT; 50% Glycerol # PV3182; Lot 286671; sequence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2020
Entry Details
Go to US Patent

TargetAurora kinase B(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 643nMAssay Description:Recombinant human Aurora B (amino acids 1-344, clone number DU1773, Molecular weight 40.2 kDa, University of Dundee) was expressed as a fusion protei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 1nMAssay Description:Human GSK3beta (expressed and prified from SF21 cells) is obtained from the University Dundee/Scotland (Dr. James Hastie—Dept. of Biochemistry) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2020
Entry Details
Go to US Patent

TargetGlycogen synthase kinase-3 beta(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 1.00E+4nMAssay Description:Human GSK3beta (expressed and prified from SF21 cells) is obtained from the University Dundee/Scotland (Dr. James Hastie—Dept. of Biochemistry) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2020
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 369nMAssay Description:FLT3 is obtained from Invitrogen in 50 mM Tris (pH7.5); 100 mM NaCl; 0.05 mM EDTA, 0.05% NP-40, 2 mM DTT; 50% Glycerol # PV3182; Lot 286671; sequence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2020
Entry Details
Go to US Patent

TargetAurora kinase B(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 643nMAssay Description:Recombinant human Aurora B (amino acids 1-344, clone number DU1773, Molecular weight 40.2 kDa, University of Dundee) was expressed as a fusion protei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 1nMAssay Description:Human GSK3beta (expressed and prified from SF21 cells) is obtained from the University Dundee/Scotland (Dr. James Hastie—Dept. of Biochemistry) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2020
Entry Details
Go to US Patent

TargetGlycogen synthase kinase-3 beta(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 1.00E+4nMAssay Description:Human GSK3beta (expressed and prified from SF21 cells) is obtained from the University Dundee/Scotland (Dr. James Hastie—Dept. of Biochemistry) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2020
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 1.35E+4nMAssay Description:FLT3 is obtained from Invitrogen in 50 mM Tris (pH7.5); 100 mM NaCl; 0.05 mM EDTA, 0.05% NP-40, 2 mM DTT; 50% Glycerol # PV3182; Lot 286671; sequence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2020
Entry Details
Go to US Patent

TargetAurora kinase B(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 5.00E+4nMAssay Description:Recombinant human Aurora B (amino acids 1-344, clone number DU1773, Molecular weight 40.2 kDa, University of Dundee) was expressed as a fusion protei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase SYK(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 27.4nMAssay Description:Human GSK3beta (expressed and prified from SF21 cells) is obtained from the University Dundee/Scotland (Dr. James Hastie—Dept. of Biochemistry) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2020
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 1.35E+4nMAssay Description:Recombinant human Syk (amino acids 342-635) was expressed as a fusion protein with an N-terminal GST tag, affinity-purified and deep-frozen at a conc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2020
Entry Details
Go to US Patent

TargetAurora kinase B(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM375942(US9914735, Example 8 | US10947243, Example 8)
Affinity DataIC50: 5.00E+4nMAssay Description:Recombinant human Aurora B (amino acids 1-344, clone number DU1773, Molecular weight 40.2 kDa, University of Dundee) was expressed as a fusion protei...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2020
Entry Details
Go to US Patent